ESC/EASD Joint Guidelines on Diabetes and Cardiovascular Diseases

被引:0
|
作者
Motz, Wolfgang [1 ]
Doerr, Rolf [2 ]
机构
[1] Klin Grp Dr Guth GmbH & Co KG, Klinikum Karlsburg, D-17495 Karlsburg, Germany
[2] Akad Lehrpraxisklin TU, Praxisklin Herz & Gefasse Kardiol Angiol Radiol N, Dresden, Germany
关键词
Diabetes mellitus; Prediabetes; Cardiovascular diseases; Coronary heart disease; Coronary artery disease equivalent; Risk factors; Coronary revascularization; CORONARY-HEART-DISEASE; DRUG-ELUTING STENTS; ELEVATION MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; BLOOD-PRESSURE; CLINICAL-OUTCOMES; GLUCOSE-TOLERANCE; RISK-FACTORS; FOLLOW-UP; MELLITUS;
D O I
10.1007/s00059-009-3203-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ESC/EASD (European Society of Cardiology/European Association for the Study of Diabetes) joint Guidelines on diabetes, pre-diabetes, and cardiovascular diseases have, for the first time, addressed diabetes mellitus and cardiovascular diseases (CVD) as a pathophysiological entity in Europe. Based on these guidelines, diabetes mellitus is regarded from the outset to be a cardiovascular disease, whose life-threatening complications myocardial infarction and stroke can only be avoided by an interdisciplinary concerted action. The most important information of these guidelines for the interdisciplinary cooperation of primary-care physicians, diabetologists and cardiologists are the postulations that patients with the main diagnosis diabetes mellitus with or without known CVD should, at regular intervals, be referred to a cardiologist, and patients with the main diagnosis CVD with or without diabetes mellitus should, at regular intervals, be referred to a diabetologist. Of fundamental importance is the prevention of diabetes and CVD by a comprehensive lifestyle modification including smoking cessation, regular physical activity and weight control, flanked by an evidence-based drug therapy. Within the framework of a multimodal risk management, an optimal antihypertensive therapy of a concomitant elevated blood pressure; a statin therapy in case of elevated LDL cholesterol or regardless of an elevated LDL in proven CVD; ACE inhibitors, angiotensin II receptor blockers, or beta-blockers in case of heart failure; and an anticoagulant therapy for the prevention of cardioembolic stroke in patients with atrial fibrillation all have class I recommendations. Concerning the preferred coronary revascularization procedure in diabetics, today no rigid general recommendation can be given in favor of or against coronary bypass surgery, or in favor of or against percutaneous coronary intervention. The decision for a specific revascularization procedure should, in any case, be based on a detailed analysis of the individual coronary anatomy.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [21] Prevention of cardiovascular diseases
    Prochaska, J. H.
    Arnold, N.
    Juenger, C.
    Muenzel, T.
    Wild, P. S.
    HERZ, 2018, 43 (01) : 87 - 98
  • [22] The burden of hyperlipidaemia and diabetes in cardiovascular diseases
    Merkler, Marijan
    Reiner, Zeljko
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 1 - 3
  • [23] Cardiovascular Disease Prevention in Rheumatoid Arthritis: Compliance with Diabetes Screening Guidelines
    Schmidt, Timothy J.
    Avina-Zubieta, J. Antonio
    Sayre, Eric C.
    Abrahamowicz, Michal
    Esdaile, John M.
    Lacaille, Diane
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (10) : 1367 - 1374
  • [24] Validity of a German Comprehensive Psychosocial Screening Instrument based on the ESC Cardiovascular Prevention Guidelines
    Van den Houdt, Sophie
    Colberg, Julian
    Samel, Christina
    Herrmann-Lingen, Christoph
    Kupper, Nina
    Albus, Christian
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2023, 69 (01): : 76 - 97
  • [25] Additive interaction of family medical history of cardiovascular diseases with hypertension and diabetes on the diagnosis of cardiovascular diseases among older adults in India
    Ahmed, Waquar
    Dixit, Priyanka
    Halli, Shiva
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [26] Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study
    Jurado, Jeronimo
    Ybarra, Juan
    Solanas, Pascual
    Caula, Jacint
    Gich, Ignasi
    Pou, Jose M.
    Romeo, June Hart
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (03): : 140 - 148
  • [27] Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    Prausmueller, Suriya
    Resl, Michael
    Arfsten, Henrike
    Spinka, Georg
    Wurm, Raphael
    Neuhold, Stephanie
    Bartko, Philipp E.
    Goliasch, Georg
    Strunk, Guido
    Pavo, Noemi
    Clodi, Martin
    Huelsmann, Martin
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [28] RELATIONSHIP BETWEEN OCCUPATIONAL STRESS AND CARDIOVASCULAR DISEASES RISK FACTORS IN DRIVERS
    Biglari, Hamed
    Ebrahimi, Mohammad Hossein
    Saleh, Maryam
    Poursadeghiyan, Mohsen
    Ahmadnezhad, Iman
    Abbasi, Milad
    INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH, 2016, 29 (06) : 895 - 901
  • [29] Early life undernutrition and chronic diseases at older ages: The effects of the Dutch famine on cardiovascular diseases and diabetes
    Portrait, France
    Teeuwiszen, Erica
    Deeg, Dorly
    SOCIAL SCIENCE & MEDICINE, 2011, 73 (05) : 711 - 718
  • [30] ESC/EAS Guidelines for the management of dyslipidaemias
    Reiner, Zeljko
    Catapano, Alberico L.
    De Backer, Guy
    Graham, Ian
    Taskinen, Marja-Riitta
    Wiklund, Olov
    Agewall, Stefan
    Alegria, Eduardo
    Chapman, M. John
    Durrington, Paul
    Erdine, Serap
    Halcox, Julian
    Hobbs, Richard
    Kjekshus, John
    Filardi, Pasquale Perrone
    Riccardi, Gabriele
    Storey, Robert F.
    Wood, David
    EUROPEAN HEART JOURNAL, 2011, 32 (14) : 1769 - 1818